Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1434-9949
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity ; volume:33 ; number:1 ; day:22 ; month:9 ; year:2013 ; pages:39-47 ; date:1.2014
Clinical rheumatology ; 33, Heft 1 (22.9.2013), 39-47, 1.2014

Creator
Takahashi, Nobunori
Kojima, Toshihisa
Kaneko, Atsushi
Kida, Daihei
Hirano, Yuji
Fujibayashi, Takayoshi
Yabe, Yuichiro
Takagi, Hideki
Oguchi, Takeshi
Miyake, Hiroyuki
Kato, Takefumi
Fukaya, Naoki
Ishikawa, Hisato
Hayashi, Masatoshi
Tsuboi, Seiji
Kanayama, Yasuhide
Kato, Daizo
Funahashi, Koji
Matsubara, Hiroyuki
Hattori, Yosuke
Hanabayashi, Masahiro
Hirabara, Shinya
Terabe, Kenya
Yoshioka, Yutaka
Ishiguro, Naoki
Contributor
SpringerLink (Online service)

DOI
10.1007/s10067-013-2392-2
URN
urn:nbn:de:101:1-2019101400352971706306
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Takahashi, Nobunori
  • Kojima, Toshihisa
  • Kaneko, Atsushi
  • Kida, Daihei
  • Hirano, Yuji
  • Fujibayashi, Takayoshi
  • Yabe, Yuichiro
  • Takagi, Hideki
  • Oguchi, Takeshi
  • Miyake, Hiroyuki
  • Kato, Takefumi
  • Fukaya, Naoki
  • Ishikawa, Hisato
  • Hayashi, Masatoshi
  • Tsuboi, Seiji
  • Kanayama, Yasuhide
  • Kato, Daizo
  • Funahashi, Koji
  • Matsubara, Hiroyuki
  • Hattori, Yosuke
  • Hanabayashi, Masahiro
  • Hirabara, Shinya
  • Terabe, Kenya
  • Yoshioka, Yutaka
  • Ishiguro, Naoki
  • SpringerLink (Online service)

Other Objects (12)

Infektionsrisiken durch Abatacept, Rituximab oder Tocilizumab analysiert

Infektionsrisiken durch Abatacept, Rituximab oder Tocilizumab analysiert

Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran

Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry

Tocilizumab: A Review in Rheumatoid Arthritis

Tocilizumab: A Review in Rheumatoid Arthritis

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies

Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis

Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis

Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study

Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study

The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis

The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis

Related objects